CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) GAIN (Unaudited) (USD $) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net revenues	$ 21,088	$ 34,316	$ 49,227	$ 64,058
Costs and operating expenses:
Cost of product sales	5,569	10,493	14,530	20,533
Selling, general and administrative expense	18,257	19,018	35,540	39,293
Research and development expense	6	82	10	610
Depreciation and amortization expense	1,430	18,215	11,295	36,762
Change in fair value of contingent consideration	(120)	(886)	143	(540)
Restructuring costs	385	31	1,214	131
Total costs and operating expenses	25,527	46,953	62,732	96,789
Loss from operations	(4,439)	(12,637)	(13,505)	(32,731)
Other income (expense):
Interest expense	(9,530)	(9,209)	(18,990)	(18,168)
Gain on sale of assets	446	0	446	0
Change in fair value of derivative liability	40	270	21	(84)
Foreign currency transaction gain	(21)	0	(21)	0
Total other expense, net	(9,065)	(8,939)	(18,544)	(18,252)
Loss before income tax expense	(13,504)	(21,576)	(32,049)	(50,983)
Income tax expense	9	40	48	95
Net loss	(13,513)	(21,616)	(32,097)	(51,078)
Other comprehensive loss:
Unrealized gain during period, net of tax of $0 and $0, respectively	0	18	0	24
Comprehensive loss	$ (13,513)	$ (21,598)	$ (32,097)	$ (51,054)
Net Loss per share, basic	$ (1.13)	$ (2.16)	$ (2.70)	$ (5.10)
Net Loss per share, diluted	$ (1.13)	$ (2.16)	$ (2.70)	$ (5.10)
Weighted-average common shares, basic	11,913	10,016	11,907	10,016
Weighted-average common shares, diluted	11,913	10,016	11,907	10,016